Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2019-06-10
2021-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuroinflammation and Postoperative Delirium in Cardiac Surgery
NCT02688179
Postoperative Delirium in Patients Undergoing Cardiac Surgery
NCT07239648
An Intervention to Reduce Delirium After Cardiac Surgery
NCT02587039
Perioperative Risk Factors for Intensive Care Delirium After Cardiac Surgery
NCT02743689
Cerebrolysin in Prevention of Postoperative Delirium in Cardiac Surgery
NCT05864677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study cohort
Patients undergoing surgery under cardiopulmonary bypass
Metabolomic analysis
Blood will be collected in all patients blood before surgery and after surgery (postoperative day 1). Our study is based on a polar metabolomics profiling of plasma and/or serum using hybrid triple quadrupole mass spectrometer coupled with chromatographic system.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Metabolomic analysis
Blood will be collected in all patients blood before surgery and after surgery (postoperative day 1). Our study is based on a polar metabolomics profiling of plasma and/or serum using hybrid triple quadrupole mass spectrometer coupled with chromatographic system.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 60 years
* CABG surgery or valve surgery (repair/replacement)
Exclusion Criteria
* surgery on aorta
* combined procedures (CABG+valves)
* significant stenosis of carotid arteries
* Parkinson's disease
* liver cirrhosis
* use of anticholinergic drugs, antidepressants, antiepileptic or chemotherapy drugs
60 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novosibirsk State University
OTHER
Meshalkin Research Institute of Pathology of Circulation
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
E. Meshalkin National Medical Research Center
Novosibirsk, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Vladimir Lomivorotov
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DEL2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.